Accriva Hemochron Jr. APTT Test Cuvettes Recalled for Reagent Defect
Accriva Diagnostics is recalling Hemochron Jr. APTT test cuvettes due to a mispositioned or absent clot activating reagent that may cause erroneous high results.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as Class II by the FDA. The source describes a hazard where erroneous test results could lead to inadequate anticoagulant therapy and thrombosis, but it does not report any illnesses, injuries, or deaths.
Plain-English summary
Accriva Diagnostics, Inc. is recalling 28,710 units of the Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103. The recall involves specific lots with expiration dates ranging from October 2026 to April 2027. The product was distributed nationwide in the United States and in China and Colombia.
The recall is being conducted because the microcoagulation test, used to evaluate low-dose heparin anticoagulation, may have a mispositioned or absent clot activating reagent. This defect may result in out-of-range high error codes or erroneously high test results. Such errors may lead to retesting or an overestimation of a patient's anticoagulation status, potentially resulting in inadequate anticoagulant therapy and an increased risk of thrombosis.
Healthcare facilities and users of the Hemochron Jr. system should stop using the affected cuvettes and contact Accriva Diagnostics for instructions on returning the product. The source text does not report any illnesses, injuries, or deaths associated with this recall.
The recalled product
- Product
- Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103
- Manufacturer
- Accriva Diagnostics, Inc.
- Category
- Medical Device — Diagnostic Test
- Affected units
- 28,710
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- UDI-DI: 10711234103012
- Lot(Expiration): B6JCA005(02/28/2027)
- C6JCA008(03/31/2027)
- D6JCA011(04/30/2027)
- K5JCA041(10/31/2026)
- C6JCA007(03/31/2027)
Distribution
Related recalls
Same manufacturer · Accriva Diagnostics, Inc.
See all →- ModeratedirectCHECK whole blood control labeled with incorrect performance range
FDA (Devices) · 2026-06-24
- HighClotting time test cuvettes recalled over a sharp-edged foreign object
FDA (Devices) · 2025-12-10
- ModeratePlatelet reactivity tests recalled after an uncleared device was distributed
FDA (Devices) · 2025-11-19
- HighVerifyNow P2Y12 Platelet Reactivity Test distributed without FDA market clearance
FDA (Devices) · 2025-01-22
- HighBlood Oximeter Calibration Error Causes Inaccurate Oxygen Readings
FDA (Devices) · 2024-11-06
Same hazard · mis labeling
See all →- Moderate
- SevereHouse Foods Recalls Seitan Cubes Due to Missing Wheat Allergen Labeling
FDA (Food) · 2026-11-11
- ModerateSmith & Nephew Recalls Mislabelled Tibia Plate Implants
FDA (Devices) · 2026-11-11
- ModerateEthel's Gluten Free Turtle Dandy Dessert Bars Recalled for Labeling Errors
FDA (Food) · 2026-11-11
- HighCrystal Temptations Chocolatey Eyeballs Recalled for Undeclared Milk Allergen
FDA (Food) · 2026-11-11
Similar recalls
- ModerateAccriva APTT Cuvettes Recalled Due to Mis-positioned Reagent
FDA (Devices) · 2016-06-01
- ModerateITC-Nexus Dx Recalls Hemochron Jr. APTT Cuvettes Due to Test Errors
FDA (Devices) · 2014-07-30
- HighITC-Nexus Dx Recalls Hemochron Jr. Citrate APTT Cuvettes for Inaccurate Results
FDA (Devices) · 2014-02-12
- HighClotting time test cuvettes recalled over a sharp-edged foreign object
FDA (Devices) · 2025-12-10
- HighAlinity c Hemoglobin Reagent Kit Recall Due to Potentially Falsely Elevated Results
FDA (Devices) · 2022-08-03
- HighHelena Laboratories Recalls Cascade Abrazo aPTT Test Cards for Clot Time Issues
FDA (Devices) · 2021-02-17